{"database": "lobbying", "table": "lobbying_activities", "rows": [[2963148, "fb33fc1e-5626-4c68-8a2d-09eb09e49b51", "Q1", "ELI LILLY AND COMPANY", 13392, "ELI LILLY AND COMPANY", 2023, "first_quarter", "CSP", "Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access", "Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", 0, 0, "2023-04-18T07:57:48-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2963148"], "units": {}, "query_ms": 12.410395982442424, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}